Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

969
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
969
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

522
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
522
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

523
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
523
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

884
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
884
Analgesia and Pain Management01:25

Analgesia and Pain Management

923
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
923
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

3.2K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral Nerve Stimulation of the Sacral Lateral Branches for Sacroiliac Joint Pain: A Technical Report.

Pain practice : the official journal of World Institute of Pain·2026
Same authorSame journal

Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Pain physician·2026
Same author

Neurovascular Compression Syndromes of Cranial Nerves: A Multidisciplinary Guide to Management.

Brain sciences·2026
Same author

A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Epidural Regenerative Medicine Therapies in Managing Spinal Pain.

Current pain and headache reports·2026
Same author

The Utility of Caudal Epidural Steroid Injections: A Comprehensive Review.

Orthopedic reviews·2026
Same author

Radiofrequency ablation of C2-3 medial branches/third occipital nerve to treat cervicogenic headache.

Annals of palliative medicine·2026

Related Experiment Video

Updated: Oct 13, 2025

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

9.7K

Combination Intrathecal Drug Therapy Strategies for Pain Management.

Jay Karri1, Mani Singh2, Devas J Modi2

  • 1Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX.

Pain Physician
|November 18, 2021
PubMed
Summary
This summary is machine-generated.

Combination intrathecal drug therapy (CIDT) offers effective pain relief for chronic conditions. However, limited evidence and potential adverse effects necessitate careful patient monitoring and individualized treatment approaches for optimal safety and efficacy.

Keywords:
bupivacainechronic painclonidinemorphinepolyanalgesiaziconotideIntrathecal

More Related Videos

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.4K
A Modified Method for Intrathecal Catheterization in Rats
11:15

A Modified Method for Intrathecal Catheterization in Rats

Published on: February 14, 2025

2.0K

Related Experiment Videos

Last Updated: Oct 13, 2025

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

9.7K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.4K
A Modified Method for Intrathecal Catheterization in Rats
11:15

A Modified Method for Intrathecal Catheterization in Rats

Published on: February 14, 2025

2.0K

Area of Science:

  • Pain Management
  • Pharmacology
  • Neurology

Background:

  • Combination intrathecal drug therapy (CIDT) is used for complex pain syndromes when other treatments fail.
  • Evidence supporting specific CIDT combinations and their off-label use is often limited.
  • Understanding CIDT requires analyzing clinical indications, pharmacologic parameters, and safety profiles.

Purpose of the Study:

  • To provide an evidence-based narrative on CIDT strategies.
  • To analyze literature regarding clinical indications, drug combinations, and safety.
  • To explore future directions for CIDT in pain management.

Main Methods:

  • A comprehensive literature review was conducted.
  • An evidence-based narrative was developed through extensive research.
  • Analysis focused on existing studies and clinical data.

Main Results:

  • CIDT leverages intrathecal pharmacokinetics/pharmacodynamics for improved analgesia but carries risks of adverse effects.
  • Evidence for CIDT in chronic pain is limited, often from small, uncontrolled studies with confounding factors.
  • Well-evidenced CIDT strategies include morphine-ziconotide, opioid-clonidine, and morphine-bupivacaine, with the latter potentially reducing opioid escalation.

Conclusions:

  • CIDT and polyanalgesia can effectively treat chronic pain patients.
  • Risks of adverse effects are patient and scenario-dependent, requiring vigilant monitoring.
  • Maintaining a low threshold for detecting adverse effects is crucial for safe CIDT use.